"Strengthening Honors for Blood Donation Contributors"… Amendment to the Blood Management Act Enforcement Decree

The supply of 'raw plasma,' the manufacturing material for blood-derived medicinal products, will become more stable. The recognition program for blood donors will also be concretized.

Blood donation bus stock photo.

The Ministry of Health and Welfare announced that the partial amendment to the 'Blood Management Act Enforcement Decree,' which includes these provisions, was approved at the Cabinet meeting on the 2nd. The amended enforcement decree will take effect from June 22.

According to this amendment, to ensure the stable supply of raw plasma, an annual supply plan will be established and implemented, and necessary data and information can be requested from blood centers and pharmaceutical companies. Raw plasma is the component obtained by centrifuging human blood to remove blood cells and platelets, and it is used in the manufacture of blood-derived medicinal products such as albumin.

Additionally, specific grounds have been established to support merit events for blood donors and blood donation education and promotional activities to encourage blood donation, aiming to contribute to the revitalization of blood donation and the cultivation of a blood donation culture.

Furthermore, to expand expert participation, the number of members in the subcommittee of the Blood Management Committee has been changed from up to 7 to up to 10 members.

Park Hyang, Director of Public Health Policy at the Ministry of Health and Welfare, stated, "By strengthening the recognition of blood donors, the culture of blood donation is expected to be revitalized, and by establishing a stable supply management system for raw plasma, the stability and efficiency of raw plasma supply will be enhanced."

This content was produced with the assistance of AI translation services.